Our analysis confirms high flap survival rates, even in emergency scenarios, and demonstrates a clear trend toward improved outcomes over time—likely attributable to greater surgical experience, technical refinements, and more accurate preoperative planning.
Although not reaching statistical significance, there was a favorable trend toward slowed global VF MD progression after supplementation began, suggesting a possible neuroprotective effect.
Neither access type nor closure device was significantly associated with major vascular complications; treatment with IVL remained associated with a lower, though borderline non-significant, risk of complications ( Table A1 ).
Notably, prior exposure to dupilumab did not affect treatment response, and both upadacitinib doses demonstrated comparable efficacy, although the 30 mg dose showed a trend toward greater pruritus reduction at week 16 [ 23 ].
This analysis highlighted xanthine metabolites ( inosine, xanthosine, xanthine, and hypoxanthine) as highly significant and predictive for PD, showing a consistent pattern of increased abundance in de novo patients compared to controls.
Similar values with a decreasing trend over the analyzed periods were observed for abnormal CT lung scans, which correspond to the diagnosis of pneumonia in 24% and 19% of patients, respectively.
Briefly, in the presence of a low cardiac index (<2.2 L/min/m 2 ) or at least two signs of hypoperfusion—such as pulse pressure variation ≥ 10%, oliguria (<0.3 mL/kg/h), hemoconcentration (increase in hematocrit without blood transfusion), lactate increase >1 mmol/L with a minimum absolute value of 2 mmol/L, a negative trend in base excess with negative absolute values, or a heart rate increase > 10% while anesthesia depth and catecholamine infusion remain stable—we perform a mini fluid challenge by infusing 100 mL of crystalloids over 1 min to assess fluid responsiveness.
In select cases, second-generation antipsychotics may be used as augmentation—particularly if psychotic features are present—although evidence is limited and adverse effects may be significant.
TECAR therapy showed a trend toward faster normalization of neuromuscular activity and mechanical muscle properties, although the small sample size and study design limit definitive conclusions about its superiority over VT.
Furthermore, early mobilization did not increase the risk of complications such as implant failure or screw cut-out and even showed a trend toward promoting fracture healing (healing time: 10.2 ± 1.8 weeks vs. 12.5 ± 2.3 weeks).
On the other hand, some pairs showed a trend since the mean difference tended to be more prominent as the average increased (i.e., Kobayashi–Kurotobi in RCA and LMCA ( Figure 4 a,b), de Zorzi–McCrindle ( Figure S1 ), Kurotobi and Dallaire ( Figure S2 ), or McCrindle and Olivieri ( Figure S3 ) both in all measurements).
By contrast, in the control group, no compartment demonstrated improvement in WORMS cartilage scores, and several compartments showed a trend toward deterioration.
In contrast, for pilon fractures, a longer duration of inpatient rehabilitation was associated with lower VAS scores as well, although the correlation with incapacity for work was only marginally significant.
Additionally, while comparisons in VAS leg pain outcomes were not statistically significant compared to patients undergoing non-endoscopic MIS surgery, there was a clear trend towards lower leg pain immediately post-operatively that persisted to one-year follow-up in the endoscopic group.
A similar age structure was described by other researchers [ 4 , 14 , 27 , 34 ], and a decreasing trend in the age of children undergoing gastrostomy was shown [ 23 ].
The mean difference between maternal and neonatal blood was 778.7 Carratelli units ( p < 0.001), indicating a highly significant elevation in maternal oxidative stress.
[ 78 ] demonstrated an uptick in the IVC filter use from 2005 to 2010 which was reversed to a decreasing trend following the FDA communication on IVC Filters in 2010.
Based on the provided information, you can state that tinzaparin is generally considered non-inferior to VKAs and shows a possible trend toward reduced recurrence of VTE in certain patient populations, particularly those with cancer.